UV light therapy

PROCEDURE5 trials

Conditions

Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative DiseasesNo Evidence of Disease

Phase 2

Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

NCT00030589

MillennixLymphoma

Start: 2001-02-28Updated: 2013-12-18

Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

CompletedNCT02090933

National Cancer Institute (NCI)No Evidence of Disease

Start: 2004-03-31End: 2004-12-31Updated: 2016-12-29

Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers

CompletedNCT02099136

National Cancer Institute (NCI)No Evidence of Disease

Start: 1999-09-30End: 2004-12-31Updated: 2016-12-29

Phase 3

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides

TerminatedNCT00056056

European Organisation for Research and Treatment of Cancer - EORTCLymphoma

Start: 2003-01-31End: 2011-06-30Updated: 2018-07-09

Unknown Phase

Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies

CompletedNCT00068523

Case Comprehensive Cancer CenterChronic Myeloproliferative Disorders, Leukemia, Lymphoma +3

Start: 2003-06-30Updated: 2020-07-27

Related Papers

Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma